Hepatocellular Cancer Terminated Phase 2 Trials for Tivozanib (DB11800)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01807156Phase II Trial of Tivozanib in Advanced Hepatocellular CancerTreatment